Respiratory Syncytial Virus (RSV) represents a significant health threat to older adults, leading to severe respiratory complications and heightened mortality rates. This focused webinar explores the significant impact of RSV in older adults, the latest advancements in RSV vaccination, and practical strategies for integrating vaccination into clinical practice. This session will guide clinicians through understanding the current burden of RSV, comparing safety and efficacy data between available vaccines, and implementing the National Advisory Committee on Immunization’s (NACI) recommendations to optimize patient outcomes. Whether you’re looking to deepen your knowledge or refine your approach to patient care, this webinar will provide valuable insights and actionable strategies.
This program has received an unrestricted educational grant or in-kind support from Moderna Biopharm Canada Inc.